ARA 290 (Cibinetide) 30mg Pre-Filled Pen
Clinical-grade support for nerve recovery.
Pre-filled multidose pen containing 30mg ARA 290 (Cibinetide) — an innate repair receptor agonist studied for neuropathic support and tissue protection.
- 3rd-party verified
- Cold-chain shipping
- Discreet packaging
- 99.8% purity
What it is
ARA 290 (Cibinetide) is a Xenogenix pre-filled multidose pen delivering an erythropoietin-derived peptide that selectively targets the innate repair receptor without haematopoietic effects.
Key benefits
- Supports nerve repair and neuropathic comfort
- Tissue-protective signalling
- May support metabolic and inflammatory balance
- Convenient pre-filled pen — no reconstitution
How it works
ARA 290 activates the innate repair receptor (IRR), triggering tissue-protective and anti-inflammatory pathways involved in nerve fibre repair.
Who it's best for
- Nerve recovery protocols
- Neuropathic discomfort support
- Advanced repair stacks
Suggested protocol
Follow guided dosing based on your nerve-recovery plan.
Administration guide
Subcutaneous via the Xenogenix pre-filled pen. Rotate injection sites.
Storage instructions
Refrigerate at 2–8 °C. Protect from light.
Frequently asked questions
How quickly will I notice results from ARA 290?
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Can I stack this with other Peak Protocol products?
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Is this third-party tested?
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
What is the return policy?
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.
